Cosmo Pharmaceuticals N.V. (0RGI.L) LSE

104.74

+2.74113(+2.69%)

Updated at December 23 05:44PM

Currency In CHF

Valuation

Market Cap1.11B
Enterprise Value1.07B
P/E Ratio32.62
PEG Ratio-0.55
Price/Sales Ratio9.9
Price/Book Ratio3.92
Enterprise/Revenue9.63
Enterprise/EBITDA23.01

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.3
Operating Margin0.33

Management Effectiveness

Return On Assets0.09
Return On Equity0.12

Income Statement

Revenue266.79M
Revenue/Share11.45
Gross Profit246.92M
EBITDA165.71M
Net Income133.24M
Diluted EPS8.12

Balance Sheet

Total Cash126.63M
Total Cash/Share3.26
Total Debt2.7M
Total Debt/Equity0.01
Current Ratio3.84
Book Value Per Share29.33

Price History

52-Week Change64.95
52-Week High105.6
52-Week Low33.75
Moving Average 50 Days63.2
Moving Average 200 Days48.12

Statistics

Average Volume1,442
Shares Outstanding15.94M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate2.06
Trailing Annual Dividend Yield1.82
Payout Ratio1.02
Last Split FactorN/A
Last Split DateN/A